All In Biotech

Drug Trial Radar · NCT06001177

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 In Participants With Celiac Disease

Last checked: Nov 19, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

55

Actual

Start

Dec 13, 2023

Primary completion

Jan 3, 2025

Study completion Jan 13, 2025

Sponsor

Sponsor type
Industry
Collaborators
Pfizer
First posted
Aug 21, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study goal is to evaluate the efficacy, safety, and tolerability of KAN-101 in participants with Celiac Disease (CeD)

Conditions

  • Celiac Disease
  • Coeliac Disease

Interventions

  • KAN-101Drug

    Dose KAN-101 Intravenous (IV) Infusion

  • PlaceboDrug

    Placebo Intravenous (IV) Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes From Baseline in Villous Height to Crypt Depth (Vh:Cd) as Assessed by Esophagogastroduodenoscopy With Biopsy After 2-week Gluten Challenge (GC)Time frame: Baseline and Day 29

Locations

28 sites in 8 countries. Site status is shown where the registry gives one.

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado

  • Unlimited Medical Research Group

    Hialeah Gardens, Florida

  • Homestead Associates in Research Inc.

    Miami, Florida

  • Alliance for Multispecialty Research, LLC

    Wichita, Kansas

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • McMaster University

    Hamilton, Ontario, Canada

  • LHSC

    London, Ontario, Canada

  • Centre Intégré de Santé et de Services Sociaux-Chaudière Appalaches - Hôtel-Dieu de Lévis

    Lévis, Quebec, Canada

  • Hopital Du Sacre-Coeur De Montreal

    Montreal, Quebec, Canada

  • Diex Recherche Quebec Inc.

    Québec, Quebec, Canada

  • Tays Research Services

    Tampere, Pirkanmaa, Finland

  • Clinical Research Services Turku

    Turku, Southwest Finland, Finland

  • CRST Helsinki Oy

    Helsinki, Uusimaa, Finland

  • Studiengesellschaft BSF Unternehmergesellschaft

    Halle, Saxony-Anhalt, Germany

  • Connolly Hospital

    Dublin, Dublin, Ireland

  • Our Lady of Lourdes Hospital

    Drogheda, Louth, Ireland

  • Midland Regional Hospital Mullingar

    Mullingar, Westmeath, Ireland

  • Rabin Medical Center

    Petah Tikva, Central District, Israel

  • Sheba Medical Center

    Ramat Gan, Central District, Israel

  • Shaare Zedek Medical Center

    Jerusalem, Jerusalem, Israel

  • Soroka Medical Center

    Beersheba, Southern District, Israel

  • Albert Schweitzer Ziekenhuis, locatie Dordwijk

    Dordrecht, South Holland, Netherlands

  • Gastromed Sp. z o. o.

    Torun, Kuyavian-Pomeranian Voivodeship, Poland

  • Centrum Medyczne Med-Gastr Sp. z o.o.

    Lodz, Łódź Voivodeship, Poland

  • Melita Medical

    Wroclaw, Lower Silesian Voivodeship, Poland

  • WIP Warsaw IBD Point Profesor Kierkuś

    Warsaw, Masovian Voivodeship, Poland

  • MZ Badania Slowik Zymla Spolka Jawna

    Knurów, Silesian Voivodeship, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.